Eliem Therapeutics’ $60-Million Series B Financing

Brown Rudnick LLP advised Eliem Therapeutics on the deal.Eliem Therapeutics Inc. recently closed on a $60-million Series B financing.  Eliem is a clinical-stage biotechnology company focused…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now